Has Peter Attia confirmed using testosterone replacement therapy?

Yes. Attia has publicly confirmed his use of TRT in multiple podcast episodes of The Drive and in his book *Outlive*. He has discussed it as part of his approach to maintaining muscle mass, bone density, and metabolic health as he ages.

Has Peter Attia confirmed using rapamycin?

Yes. Attia has publicly confirmed weekly off-label use of rapamycin (sirolimus) at a low dose, approximately 5 to 6 mg once per week. He has discussed this in detail across multiple episodes of The Drive podcast and in his newsletter.

Will insurance cover rapamycin for anti-aging?

No. Rapamycin (sirolimus) is FDA-approved only for organ transplant rejection prophylaxis and lymphangioleiomyomatosis. Pharmacy benefit managers will not authorize coverage for longevity or anti-aging use. Patients using rapamycin off-label should expect to pay entirely out of pocket.

Is rapamycin safe for healthy people?

Long-term safety data in healthy adults is limited. Short-term studies using intermittent low-dose protocols have shown a tolerable side effect profile, but rapamycin can raise lipids, impair glucose tolerance, and suppress immune function at higher doses. The Mannick et al. (2018) study demonstrated improved immune function with intermittent mTOR inhibition in elderly subjects, but larger and longer trials are still needed.

Can I get TRT through a telehealth clinic?

Yes. Several telehealth platforms now prescribe TRT after verifying low testosterone through lab work. Costs for intake consultations typically range from $100 to $200, with ongoing monthly fees of $50 to $150 depending on the platform and whether labs are bundled.

What is the cheapest way to replicate this protocol?

Generic testosterone cypionate with self-injection is the lowest-cost TRT option ($70 to $180/year for the drug). Generic sirolimus through a discount pharmacy or compounding pharmacy is the lowest-cost rapamycin option ($520 to $1,300/year). Direct-to-consumer lab services reduce monitoring costs. The floor for both medications with adequate monitoring is approximately $1,400 per year.

What Peter Attia's Longevity / TRT Protocol Would Cost Outside a Celebrity Context

By HealthRX.com Medical Team

Published May 25, 2026Updated May 25, 2026Last reviewed May 25, 2026

Clinical image for What Peter Attia's Longevity / TRT Protocol Would Cost Outside a Celebrity Context Image: HealthRX.com clinical image

What Peter Attia Has Publicly Confirmed

Peter Attia, a physician specializing in longevity medicine and the author of Outlive: The Science and Art of Longevity, has been unusually transparent about his own pharmacological regimen. In multiple long-form podcast appearances and in Outlive itself, Attia confirmed that he uses testosterone replacement therapy. He has also publicly confirmed weekly off-label use of rapamycin (sirolimus), an mTOR inhibitor originally approved as an immunosuppressant, which he takes at a low dose for its proposed geroprotective effects.

These are not rumors. Attia discussed his TRT use during episodes of The Drive podcast and in multiple public interviews. His rapamycin protocol has been detailed across several podcast episodes and newsletter posts, including dose, frequency, and monitoring bloodwork.

The gap between knowing what Attia takes and being able to access the same medications as an ordinary patient is enormous. That gap is the subject of this page.

Testosterone Replacement Therapy: What It Actually Costs

TRT is the more accessible half of this regimen, but "accessible" is relative.

Generic testosterone cypionate, the most commonly prescribed injectable form in the U.S., costs between $30 and $90 per 10 mL vial at retail pharmacy pricing without insurance. A typical dose of 100 mg per week means one vial lasts roughly five months. With a GoodRx coupon, patients frequently pay under $50 for a vial. That sounds cheap. It is not the full picture.

The real costs stack up around the prescription itself. Most endocrinologists and urologists require baseline labs (total testosterone, free testosterone, LH, FSH, CBC, lipid panel, PSA) before initiating therapy. A full panel can run $200 to $500 without insurance. Follow-up labs are recommended every 6 to 12 months per Endocrine Society guidelines, and many clinicians check hematocrit quarterly in the first year due to the risk of erythrocytosis, a well-documented side effect where red blood cell mass increases beyond safe thresholds (Bachman et al., 2010, JAMA).

Insurance coverage for TRT varies dramatically. Most commercial insurers will cover testosterone cypionate injections when the diagnosis is confirmed hypogonadism (ICD-10 E29.1) with two morning serum testosterone levels below roughly 300 ng/dL. If your levels sit at 350 ng/dL and you feel terrible, many insurers will deny the claim. Patients pursuing TRT for optimization rather than deficiency, the framing Attia often uses, should expect to pay entirely out of pocket.

The HealthRX.com Medical Team's estimate for year-one TRT costs without insurance:

| Item | Estimated Cost | |---|---| | Initial consultation (endocrinologist or men's health clinic) | $150 to $400 | | Baseline labs | $200 to $500 | | Testosterone cypionate, 1 year supply | $70 to $180 | | Syringes, needles, alcohol swabs | $30 to $60 | | Follow-up labs (2 to 3 panels) | $300 to $900 | | Follow-up visits (2 to 3) | $200 to $600 | | Total | $950 to $2,640 |

Telehealth TRT clinics have compressed some of these costs. Companies like Defy Medical or Marek Health charge $100 to $200 for intake consultations and bundle labs at negotiated rates. The tradeoff is reduced continuity with a single provider.

Rapamycin: The Harder Prescription to Get

Rapamycin (brand name Rapamune, generic sirolimus) is where the access story gets difficult. The FDA approved sirolimus for prophylaxis of organ rejection in renal transplant recipients and for lymphangioleiomyomatosis. Using it for longevity is entirely off-label.

Off-label prescribing is legal. Physicians do it routinely. But most doctors will not prescribe rapamycin for anti-aging purposes because the evidence base, while growing, consists primarily of animal studies and small human trials. The landmark TORC1 inhibition study by Mannick et al. (2014) showed that an mTOR inhibitor improved immune function in elderly subjects, and subsequent work has demonstrated reduced infection rates. These results are promising. They are not sufficient for most clinicians to write a prescription for an immunosuppressant in healthy patients.

Attia has discussed taking rapamycin at approximately 5 to 6 mg once weekly, a dose significantly lower than transplant protocols (which typically run 2 to 5 mg daily). At this intermittent schedule, the immunosuppressive effects appear to be minimal based on available data, but the long-term safety profile in healthy adults is unknown. A 2023 review in The Lancet Healthy Longevity summarized the state of evidence and concluded that large-scale randomized trials are still needed.

Cost of rapamycin without insurance:

Generic sirolimus 1 mg tablets run $2 to $5 per tablet at retail pharmacies with discount pricing. At 5 mg once weekly, that is $10 to $25 per week, or roughly $520 to $1,300 per year for the drug alone. Brand-name Rapamune is substantially more expensive (upward of $800 per month) and unnecessary for most patients since the generic is bioequivalent.

Insurance will not cover rapamycin for longevity. Prior authorization for sirolimus requires a transplant diagnosis or an LAM diagnosis. No amount of clinical notes about mTOR inhibition and geroprotection will satisfy a pharmacy benefit manager reviewing this claim.

Compounding pharmacies offer another route. Some longevity clinics work with compounding pharmacies that produce sirolimus at lower per-unit costs, sometimes under $1 per milligram. This approach carries its own risks: compounded medications are not subject to the same FDA oversight as manufactured generics, and quality can vary between pharmacies.

The Monitoring Stack

Both medications require ongoing bloodwork that adds significant recurring cost.

For TRT, standard monitoring includes CBC (watching hematocrit), metabolic panel, lipids, testosterone and estradiol levels, and PSA for men over 40. The Endocrine Society's 2018 guidelines recommend these at 3 to 6 months after initiation and annually thereafter.

Rapamycin monitoring is less standardized given its off-label status, but Attia and other longevity physicians typically check sirolimus trough levels, CBC with differential (watching for leukopenia), fasting lipids (rapamycin can raise triglycerides and LDL), fasting glucose and HbA1c (mTOR inhibition can impair glucose tolerance), and liver function. A 2020 study in Science Translational Medicine confirmed dose-dependent lipid elevations with mTOR inhibitors, making regular monitoring essential.

For a patient running both medications with quarterly labs in year one and semi-annual labs after that, expect to spend $400 to $1,200 annually on bloodwork alone if paying out of pocket. Direct-to-consumer lab services (Ulta Lab Tests, Quest through self-order) can reduce this to $200 to $600 per year.

Finding a Prescriber

This is the bottleneck most patients underestimate.

Your primary care physician is unlikely to prescribe rapamycin for longevity. Most PCPs have limited familiarity with mTOR biology and reasonable concerns about liability. TRT is somewhat easier to obtain through a PCP, but many still refer to endocrinology.

Concierge longevity practices, the type of practice Attia ran at Attia Medical before transitioning to media and writing, charge $5,000 to $50,000 per year in membership fees. These fees grant access to physicians comfortable with off-label longevity prescribing. For patients who cannot afford concierge medicine, a smaller number of telemedicine practices now offer rapamycin consultations for $200 to $500 per visit.

The HealthRX.com Medical Team notes that the willingness of a clinician to prescribe is not, by itself, evidence of appropriateness. Any physician prescribing rapamycin off-label should be running comprehensive baseline labs, discussing the limited human evidence, documenting informed consent, and committing to regular follow-up monitoring.

Total Annual Cost: The Realistic Range

At a glance

TRT alone (generic cypionate, self-inject): $600 to $1,500/year including labs and visits
Rapamycin alone (generic sirolimus, weekly dosing): $800 to $2,000/year including labs and prescriber visits
Both medications combined: $1,400 to $3,500/year without concierge fees
With a concierge longevity practice: $6,400 to $53,500/year
Insurance coverage for longevity use: functionally zero for rapamycin, partial for TRT if hypogonadism is documented

The HealthRX.com Medical Team Take

Peter Attia's transparency about his protocol is genuinely unusual among physicians. He names the drugs, discusses the doses, and acknowledges the uncertainty. The problem is not that the information is hidden. The problem is that the medical and insurance infrastructure in the United States was not built to support elective longevity pharmacology.

A patient earning a median household income who wants to replicate the confirmed portions of Attia's protocol faces three barriers: finding a clinician who will prescribe rapamycin off-label, absorbing $1,400 to $3 to 500 in annual out-of-pocket costs (more with a concierge practice), and accepting the risk of using a potent immunomodulator without long-term safety data in healthy populations. Each of these barriers is real. None of them is discussed in a typical podcast episode about "optimizing healthspan."

The HealthRX.com Medical Team supports evidence-informed longevity medicine. We also believe patients deserve honest accounting of what these protocols cost outside the bubble of concierge care and physician self-experimentation.

Frequently asked questions

›

References

Bachman E, et al. "Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin." JAMA. 2010. https://jamanetwork.com/journals/jama/fullarticle/185665
Bhasin S, et al. "Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab. 2018. https://pubmed.ncbi.nlm.nih.gov/29562364/
Mannick JB, et al. "mTOR inhibition improves immune function in the elderly." Sci Transl Med. 2014. https://pubmed.ncbi.nlm.nih.gov/25540326/
Mannick JB, et al. "TORC1 inhibition enhances immune function and reduces infections in the elderly." Sci Transl Med. 2018. https://pubmed.ncbi.nlm.nih.gov/30068905/
Kaeberlein M, Galvan V. "Rapamycin and Alzheimer's disease: Time for a clinical trial?" Lancet Healthy Longev. 2023. https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00258-1/fulltext
FDA. Rapamune (sirolimus) prescribing information. https://www.accessdata.fda.gov/drugsatfda_cds/label/2017/021083s064,021110s076lbl.pdf
Endocrine Society. Testosterone Therapy Clinical Practice Guidelines. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy